Table 3.
Total | Females | Males | |||||||
---|---|---|---|---|---|---|---|---|---|
2019/03–12 | 2020/03–12 | 2019/03–12 | 2020/03–12 | 2019/03–12 | 2020/03–12 | ||||
Total | 291,722,002 | 286,450,149 | −1.8% | 182,832,460 | 179,872,718 | −1.6% | 108,888,844 | 106,576,663 | −2.1% |
Antidepressants (N06A) | 178,777,672 | 177,707,840 | −0.6% | 118,669,761 | 118,279,653 | −0.3% | 60,107,583 | 59,427,419 | −1.1% |
Antipsychotics (N05A) | 31,624,152 | 31,896,314 | 0.9% | 16,111,898 | 16,249,260 | 0.9% | 15,512,254 | 15,647,054 | 0.9% |
Anxiolytics (N05B) and hypnotics (N05C) | 32,721,180 | 29,532,437 | −9.7% | 18,500,862 | 16,616,733 | −10.2% | 14,220,318 | 12,915,704 | −9.2% |
Antidementia drugs (N06D) | 42,523,158 | 41,094,775 | −3.4% | 27,969,087 | 27,098,848 | −3.1% | 14,553,991 | 13,995,927 | −3.8% |
Others (N06B and N07B) | 6,075,840 | 6,218,783 | 2.4% | 1,580,852 | 1,628,224 | 3.0% | 4,494,698 | 4,590,559 | 2.1% |